Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy TEWKSBURY, Mass., April 1, 2022 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its global, phase III REDUCE LAP-HF II randomized trial of heart failure […]
Other News
Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
An analysis showed benefit of XARELTO® plus aspirin in reducing thrombotic hospitalizations for PAD patients with and without chronic kidney disease (CKD) A separate analysis demonstrated PAD patients who received XARELTO® plus aspirin in addition to statin therapy had the lowest risk of the composite of major adverse cardiovascular events (MACE) or major adverse […]
East End Medical Announces First Commercial Use of its Novel All-in-One SafeCross™ Transseptal RF Puncture and Steerable Balloon Introducer System
MIAMI, April 1, 2022 /PRNewswire/ — East End Medical, a private medical device company committed to improving catheter-based cardiac procedures, today announced the first commercial uses of its SafeCross™ Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The All-in-One system is designed to provide a predictable and safe solution for performing electrophysiology and […]
Medscape, American College of Cardiology Launch Latin America Center for Cardiovascular Health Promotion
New collaboration to deliver information and resources targeted to the needs of physicians throughout Latin America NEW YORK, April 1, 2022 /PRNewswire/ — Medscape and the American College of Cardiology (ACC) today announced the launch of the Latin America Center for Cardiovascular Health Promotion (Spanish and Portuguese), a new collaboration that will deliver trusted scientific information and […]
Venus Medtech announces 2021 annual results: pacesetter in China and breakthrough-maker worldwide
HANGZHOU, China, March 31, 2022 /PRNewswire/ — On March 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as “Venus Medtech”), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced its annual results for the year ended December 31, 2021. According to the financial report, Venus Medtech recorded RMB416 […]
Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization
TEL AVIV, Israel, March 31, 2022 /PRNewswire/ — Radiaction Medical Ltd. (“Radiaction”), an innovative medical device company focused on radiation protection in the interventional cardiology and electrophysiology sectors, announced FDA 510(K) clearance for the marketing of its Shield System in the US. In addition, the company has completed a $10 million round of financing led by […]
Philips showcases new innovations in the treatment of heart rhythm disorders at EHRA 2022
April 1, 2022 Integrated portfolio for atrial fibrillation offers solutions across electrophysiology, cardiac implantable electronic device (CIED) lead extraction and ECG monitoring New release of KODEX-EPD cardiac imaging and mapping system from Philips incorporates new innovations for RF and cryoballoon therapy for cardiac arrhythmias Philips reinforces its commitment to facilitating adherence to international best-practice guidelines for […]
Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 1 April 2022, 07:00 CET LIÈGE, Belgium , April 01, […]
Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes
Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of EPA/atorvastatin active metabolite (ATM) and of EPA/rosuvastatin (rosuva) reduced lipid oxidation by 86% and 75%, respectively (p<0.001) DUBLIN, Ireland and BRIDGEWATER, N.J., April 01, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc […]
Spacelabs Healthcare Showcases New Products at Upcoming American College of Cardiology Scientific Sessions and Expo
SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare, a division of OSI Systems, Inc. (“OSI Systems”), today announced that it will be demonstrating new diagnostic cardiology products at the American College of Cardiology’s (“ACC”) 71st annual event. Attendees will have an opportunity to see new and recent offerings from Spacelabs Healthcare, including the Eclipse™ Pro […]



